We were surprised to find that 7 out of the 20 patients with MG were CBA negative (CBA–), which suggests that they mainly have autoAbs against intracellular parts of the receptor, since these patients were RIPA positive against the native nAChR. This evidence concerns the gene CHRNA4 and myasthenia gravis.